Ethiopia has officially declared the end of its first-ever Marburg virus disease (MVD) outbreak following sustained control measures and surveillance that met global outbreak-management standards. The Ministry of Health announced on 26 January 2026 that two full consecutive incubation periods (42 days) passed without any new confirmed case since the last MVD fatality was safely and respectfully buried. This declaration aligns with established international outbreak guidelines and reflects coordinated public health implementation since the first confirmed case in November 2025.
The outbreak first emerged in Jinka town, South Ethiopia Region, when clinicians recognised a viral haemorrhagic fever and notified national authorities. Laboratory testing at the Ethiopian Public Health Institute confirmed Marburg virus in mid-November 2025, marking Ethiopia’s first documented MVD event. Health authorities promptly activated emergency response structures to trace contacts, isolate cases, and enhance case management while working under continuous World Health Organization support and technical guidance.
During the outbreak period, a cumulative total of 19 cases was reported, including 14 laboratory-confirmed and five probable cases. Of these, nine confirmed cases died, yielding a case fatality rate of over 60% among confirmed patients. Contact tracing and monitoring were extensive, with over 850 contacts followed through their 21-day risk period, and approximately 3,800 diagnostic samples tested for suspected infection. Public health teams deployed integrated surveillance, risk communication, and community engagement to minimise transmission and protect vulnerable populations.
Technical support from WHO and partners was essential in bolstering Ethiopia’s response capacity, including enhancing clinical care facilities, laboratory testing networks, and infection prevention and control practices. Coordination across national and regional health units enabled rapid case isolation and safe handling of potential exposures while maintaining essential health services in affected districts. WHO emphasised sustaining early detection and response capabilities even after the outbreak’s end, given the risk of spillover from fruit bat reservoirs and the potential for re-emergence.
Importantly, this outbreak response underscores lessons in emergency preparedness and resilient health systems. Ethiopia’s deployment of a national taskforce, activation of public health emergency operations centres, and community-level engagement demonstrate how structural readiness and real-time data can limit high-risk pathogen spread. The integration of enhanced surveillance with proactive outreach minimized panic and ensured trust in public health interventions.
Strategic significance lies in the compliance and resilience improvements this episode has catalysed. For businesses and markets, strengthened disease surveillance and response infrastructure reduces risk exposure for workforce health and continuity planning. For public health compliance, Ethiopia’s alignment with international outbreak guidelines reinforces investor confidence in regional stability. By embedding these systems for future threats, policymakers and corporations can better manage biosafety risks and uphold ESG commitments to human health and community protection.
